Skip to main content
. 2012 Jun 19;6(6):e1674. doi: 10.1371/journal.pntd.0001674

Figure 1. CONSORT Patient Flowchart – SSG vs. PM.

Figure 1

SSG, sodium stibogluconate; PM, paromomycin sulphate; SAE, serious adverse event; LTFU, loss to follow-up; ITT, intention-to-treat; PP, per protocol. Patients included in the SSG (20 mg/kg/day for 30 days) vs. PM (20 mg/kg/day for 21 days) arms; a data from these patients were previously reported [14].